Primary information |
---|
ID | antitb_1732, |
Name | US 2007/003721 |
N-Terminal modification | Seq ID No 22 |
C-Terminal Modification | YPHHFKHRHIPIGGGS |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 16 |
Source | L |
Species | Synthetic |
Strain | From random peptide libraries diplayed on bacteriophage M14 |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis |
Cell Line | 100 μM completely inhibits the cahpaeron activity of Hsp 16.3 |
Inhibition Concentration | In vitro |
Sequence | 2007 |
Cytotoxicity | Mouse bone marrow derive dmacrophages and THP-1 |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | None |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | Inhibit chaperon activity of heat shock protein 16.3 (Hsp 16.3) |
Other activities | Heat shock protein (Hsp 16.3) |
PMID | None |
Year of Publication | None |
Tertiary Structure (Technique) | Not Predicted), |